As a follow-up question to that one, where are we going in terms of production of medical isotopes after 2016 when the NRU's licence does expire? From what you've said, we have three very good projects moving forward, but what's the plan after 2016? On just the three projects, NRU combined, how are we going to deal with the needs at that point?
On April 16th, 2013. See this statement in context.